Genomic features beyond Chlamydia trachomatis phenotypes: What do we think we know?

被引:23
|
作者
Nunes, Alexandra [1 ]
Borrego, Maria J. [1 ]
Gomes, Joao P. [1 ]
机构
[1] Natl Inst Hlth, Dept Infect Dis, P-1649016 Lisbon, Portugal
关键词
Chlamydia trachomatis; Recombination; Point-mutation; Tissue tropism; Pathogenesis; Ecological success; OUTER-MEMBRANE PROTEIN; OBLIGATE INTRACELLULAR PATHOGEN; IN-VIVO; TISSUE TROPISM; GLYCOSAMINOGLYCAN BINDING; SALMONELLA-TYPHIMURIUM; TRYPTOPHAN SYNTHASE; DEVELOPMENTAL CYCLE; HOST-CELLS; GENE DECAY;
D O I
10.1016/j.meegid.2013.03.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The obligate intracellular pathogen Chlamydia trachomatis is the causative agent of the blinding trachoma and the world's leading cause of bacterial sexually transmitted infections. Despite aggressive antibacterial control measures, C trachomatis infections have been increasing, constituting a serious public health concern due to its morbidity and socioeconomic burden. Still, very little is known about the molecular basis underlying the phenotypic disparities observed among C trachomatis serovars in terms of tissue tropism (ocular conjunctiva, epithelial-genitalia and lymph nodes), virulence (disease outcomes) and ecological success. This is in part due to the inexistence of straightforward tools to genetically manipulate Chlamydiae and host cell-free growth systems, hampering the elucidation of the biological role of loci. The recent release of tenths of full-genome C trachomatis sequences depict a strains clustering scenario reflecting the organ/cell-type that they preferentially infect. However, the high degree of genomic conservation implies that few genetic features are involved in phenotypic dissimilarities. The purpose of this review is to gather the most relevant data dispersed throughout the literature concerning the genotypic evidences that support niche-specific phenotypes. This review focus on chromosomal dynamics phenomena like recombination and point-mutations, essentially involving outer and inclusion membrane proteins, type III secretion effectors, and hypothetical proteins with unknown function. The scrutiny of C trachomatis loci involved in tissue tropism, pathogenesis and ecological success is crucial for the development of disease-specific prophylaxis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 50 条
  • [41] The Infectious Hypodermal and Haematopoietic Necrosis Virus: A Brief Review of What We Do and Do Not Know
    Vega-Heredia, S.
    Mendoza-Cano, F.
    Sanchez-Paz, A.
    TRANSBOUNDARY AND EMERGING DISEASES, 2012, 59 (02) : 95 - 105
  • [42] Pathogenesis of Sjogren's syndrome: What we know and what we should learn
    Tzioufas, Athanasios G.
    Kapsogeorgou, Efstathia K.
    Moutsopoulos, Haralampos M.
    JOURNAL OF AUTOIMMUNITY, 2012, 39 (1-2) : 4 - 8
  • [43] The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?
    Kohil, Amira
    Abdalla, Wafa
    Ibrahim, Wisam N.
    Al-Harbi, Khalid M.
    Al-Haidose, Amal
    Al-Asmakh, Maha
    Abdallah, Atiyeh M.
    MEDICINA-LITHUANIA, 2023, 59 (09):
  • [44] Meconium aspiration syndrome: do we know?
    Yurdakok, Murat
    TURKISH JOURNAL OF PEDIATRICS, 2011, 53 (02) : 121 - 129
  • [45] Coronavirus disease 2019: What we know?
    He, Feng
    Deng, Yu
    Li, Weina
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) : 719 - 725
  • [46] Rethinking What We Know About Hemorrhoids
    Sandler, Robert S.
    Peery, Anne F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 8 - 15
  • [47] Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know
    Cavaletti, Guido
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2014, 19 (02) : 66 - 76
  • [48] What do we currently know from in vivo bone strain measurements in humans?
    Yang, P. F.
    Brueggemann, G-P.
    Rittweger, J.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (01) : 8 - 20
  • [49] Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So Far?
    Pyzik, Aleksandra
    Grywalska, Ewelina
    Matyjaszek-Matuszek, Beata
    Rolinski, Jacek
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [50] Genetics of glucocorticoid regulation and posttraumatic stress disorder-What do we know?
    Castro-Vale, Ivone
    van Rossum, Elisabeth F. C.
    Machado, Jose Carlos
    Mota-Cardoso, Rui
    Carvalho, Davide
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 63 : 143 - 157